Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Tax Loss selling!

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Dec 26, 2024 9:20am

126 Views

Post# 36377525

RE:Tax Loss selling!

The best thing that stops tax loss selling is reaching Dec 30 ( or Dec 31 in the US )

I'd venture to say that some, that have already triggered a loss, are considering buying back in after taking into account the 30 day rule.

MM

<< Previous

Bullboard Posts

Next >>

The top 5 Canadian small-cap AI stocks